Antibiotics Differentially Modulate Lipoteichoic Acid-Mediated Host Immune Response
Open Access
- 3 September 2020
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 9 (9) , 573
Abstract
In Staphylococcus aureus bacteremia, our group has shown that a dysregulated balance of pro- and anti-inflammatory cytokine response biased towards an immunoparalysis phenotype is predictive of persistence and mortality, despite receipt of antibiotics. Certain antibiotics, as well as lipoteichoic acid (LTA) released from S. aureus, can modulate immune response ex vivo. Here, we evaluated the effects of three anti-staphylococcal antibiotics (vancomycin, tedizolid, and daptomycin) on the expression of cytokines and cell surface markers of immune activation (TNFα, HLA-DR) and immunoparalysis (IL-10, PD-L1) in human peripheral blood mononuclear cells (PBMC) exposed to high (10 μg) and low (1 μg) doses of LTA. Results suggested a dose-dependent relationship between LTA and induction of anti- and pro-inflammatory immune responses. Differential antibiotic effects were prominently observed at high but not low LTA condition. Vancomycin significantly induced IL-10 and TNFα expression, whereas daptomycin had no effects on cytokine response or expression of cell surface receptors. Tedizolid increased TNFα and modestly increased HLA-DR expression, suggesting a stimulatory effect. These findings suggest that anti-staphylococcal agents differentially alter LTA-mediated immune cell activation status and cytokine response, providing support for future clinical studies to better elucidate the complexities of host–microbial–antibiotic interaction that can help direct precision therapy for S. aureus bacteremia.Keywords
Funding Information
- Cubist (NA)
This publication has 25 references indexed in Scilit:
- Monocyte HLA-DR in sepsis: shall we stop following the flow?Critical Care, 2014
- The function of TLR2 during staphylococcal diseasesFrontiers in Cellular and Infection Microbiology, 2013
- Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administrationThrombosis and Haemostasis, 2013
- Control of Adaptive Immune Responses by Staphylococcus aureus through IL-10, PD-L1 and TLR2Scientific Reports, 2012
- Systematic Review of Membrane Components of Gram-Positive Bacteria Responsible as Pyrogens for Inducing Human Monocyte/Macrophage Cytokine ReleaseFrontiers in Pharmacology, 2012
- Antivirulence Potential of TR-700 and Clindamycin on Clinical Isolates of Staphylococcus aureus Producing Phenol-Soluble ModulinsAntimicrobial Agents and Chemotherapy, 2011
- Daptomycin Does Not Exert Immunomodulatory Effects in an Experimental Endotoxin Model of Human Whole BloodPharmacology, 2007
- Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-α in mediating LTA-induced interleukin-8 generationCritical Care Medicine, 2006
- Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2Journal of Leukocyte Biology, 2003
- Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitmentImmunobiology, 2003